ProShare Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,741	Closed	-$224K	–	2372
2021 Q3	$224K	Sell	12,741 -12,636	-50%	-$222K	﹤0.01%	1735
2021 Q2	$246K	Buy	+25,377	New	+$246K	﹤0.01%	2019